Autosomal recessive nonsyndromic hearing impairment in two Finnish families due to the population enriched CABP2 c.637+1G > T variant




Bharadwaj Thashi, Schrauwen Isabelle, Acharya Anushree, Nouel-Saied Liz M., Väisänen Marja-Leena, Kraatari Minna, Rahikkala Elisa, Jarvela Irma, Kotimäki Jouko, Leal Suzanne M.

PublisherWILEY

2022

Molecular Genetics and Genomic Medicine

MOL GENET GENOM MED

e1866

10

3

5

2324-9269

2324-9269

DOIhttps://doi.org/10.1002/mgg3.1866

https://onlinelibrary.wiley.com/doi/10.1002/mgg3.1866

https://research.utu.fi/converis/portal/detail/Publication/175034215



Background: The genetic architecture of hearing impairment in Finland is largely unknown. Here, we investigated two Finnish families with autosomal recessive nonsyndromic symmetrical moderate-to-severe hearing impairment.

Methods: Exome and custom capture next-generation sequencing were used to detect the underlying cause of hearing impairment.

Results: In both Finnish families, we identified a homozygous pathogenic splice site variant c.637+1G>T in CAPB2 that is known to cause autosomal recessive nonsyndromic hearing impairment. Four CABP2 variants have been reported to underlie autosomal recessive nonsyndromic hearing impairment in eight families from Iran, Turkey, Pakistan, Italy, and Denmark. Of these variants, the pathogenic splice site variant c.637+1G>T is the most prevalent. The c.637+1G>T variant is enriched in the Finnish population, which has undergone multiple bottlenecks that can lead to the higher frequency of certain variants including those involved in disease.

Conclusion: We report two Finnish families with hearing impairment due to the CABP2 splice site variant c.637+1G>T.


Last updated on 2024-26-11 at 13:40